Indoco Remedies is currently trading at Rs. 395.00, up by 10.85 points or 2.82% from its previous closing of Rs. 384.15 on the BSE.
The scrip opened at Rs. 395.00 and has touched a high and low of Rs. 412.80 and Rs. 377.65 respectively. So far 86,379 shares were traded on the counter.
The BSE group 'B' stock of face value Rs. 10 has touched a 52 week high of Rs. 485.00 on 08-Jul-2011 and a 52 week low of Rs. 360.00 on 24-Oct-2011.
Last one week high and low of the scrip stood at Rs. 412.80 and Rs. 377.65 respectively. The current market cap of the company is Rs. 485.00 crore.
The promoters holding in the company stood at 61.06% while Institutions and Non-Institutions held 16.87% and 22.07% respectively.
Indoco Remedies has informed that a meeting of the board of directors of the company will be held on March 29, 2012, to consider a proposal for sub division of shares of Rs 10 each and a proposal for issue of bonus shares.
The board will also consider a proposal for increasing the Authorised Share Capital and consequent amendments to Memorandum of Association of the Company.
Indoco Remedies is engaged in the manufacturing and marketing of formulations (finished dosage forms) and active pharmaceutical ingredients (APIs) in India.
Company Name | CMP |
---|---|
Sun Pharma Inds. | 1505.20 |
Dr. Reddys Lab | 5922.45 |
Cipla | 1339.45 |
Zydus Lifesciences | 983.05 |
Lupin | 1609.85 |
View more.. |